ioxaglate has been researched along with Kidney Diseases in 20 studies
Ioxaglic Acid: A low-osmolar, ionic contrast medium used in various radiographic procedures.
ioxaglic acid : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an acetyl(methyl)amino group at the 5-position.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
Excerpt | Relevance | Reference |
---|---|---|
" Gentamicin (GE) acts mainly in proximal tubular cells, where it is uptake via organic anion transport system and it induces a high incidence of nephrotoxicity, which is characterized by tubular necrosis [5] leading to acute renal failure in 10 to 50% of patients." | 3.71 | Effects of gentamicin, lipopolysaccharide, and contrast media on immortalized proximal tubular cells. ( Cunha, MA; Schor, N, 2002) |
"Nephrotoxicity of radio-opaque contrast media (CM) is generally believed to involve toxic injury of proximal tubular cells." | 2.66 | Nephrotoxicity of high- and low-osmolality contrast media. ( Avila, A; Dennis, B; Finnie, KJ; Jevnikar, AM; Linton, AL; Plummer, DT, 1988) |
"Ozone treatment was applied for 5 days after the contrast agent was introduced in Group V." | 1.48 | An experimental study on the preventive effects of N-acetyl cysteine and ozone treatment against contrast-induced nephropathy. ( Adali, Y; Eroglu, HA; Kuzucu, M; Ozturk, O; Ustebay, S, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (20.00) | 18.7374 |
1990's | 2 (10.00) | 18.2507 |
2000's | 9 (45.00) | 29.6817 |
2010's | 4 (20.00) | 24.3611 |
2020's | 1 (5.00) | 2.80 |
Authors | Studies |
---|---|
Freitas, RAP | 1 |
Tanajura, LF | 1 |
Mehran, R | 3 |
Chamié, D | 1 |
Chaves, A | 1 |
Centemero, M | 1 |
Braga, S | 1 |
Costa, R | 1 |
Cao, D | 1 |
Sousa, A | 1 |
Feres, F | 1 |
Costa, JR | 1 |
Ozturk, O | 1 |
Eroglu, HA | 1 |
Ustebay, S | 1 |
Kuzucu, M | 1 |
Adali, Y | 1 |
Nikolsky, E | 2 |
Kirtane, AJ | 1 |
Caixeta, A | 1 |
Wong, SC | 1 |
Teirstein, PS | 1 |
Downey, WE | 1 |
Batchelor, WB | 1 |
Casterella, PJ | 1 |
Kim, YH | 1 |
Fahy, M | 1 |
Dangas, GD | 1 |
Reed, M | 1 |
Meier, P | 1 |
Tamhane, UU | 1 |
Welch, KB | 1 |
Moscucci, M | 1 |
Gurm, HS | 1 |
Angoulvant, D | 1 |
Cucherat, M | 1 |
Rioufol, G | 1 |
Finet, G | 1 |
Beaune, J | 1 |
Revel, D | 1 |
Laville, M | 1 |
Ovize, M | 1 |
André-Fouët, X | 1 |
Sendeski, M | 1 |
Patzak, A | 1 |
Persson, PB | 1 |
Barlak, A | 1 |
Akar, H | 1 |
Yenicerioglu, Y | 1 |
Yenisey, C | 1 |
Meteoğlu, I | 1 |
Yilmaz, O | 1 |
Aslanger, E | 1 |
Uslu, B | 1 |
Akdeniz, C | 1 |
Polat, N | 1 |
Cizgici, Y | 1 |
Oflaz, H | 1 |
Cunha, MA | 1 |
Schor, N | 1 |
Dangas, G | 1 |
Iakovou, I | 1 |
Aymong, ED | 1 |
Mintz, GS | 1 |
Kipshidze, NN | 1 |
Lansky, AJ | 1 |
Moussa, I | 1 |
Stone, GW | 1 |
Moses, JW | 1 |
Leon, MB | 1 |
Gomes, VO | 1 |
Poli de Figueredo, CE | 1 |
Caramori, P | 1 |
Lasevitch, R | 1 |
Bodanese, LC | 1 |
Araújo, A | 1 |
Röedel, AP | 1 |
Caramori, AP | 1 |
Brito, FS | 1 |
Bezerra, HG | 1 |
Nery, P | 1 |
Brizolara, A | 1 |
Dussol, B | 1 |
Morange, S | 1 |
Loundoun, A | 1 |
Auquier, P | 1 |
Berland, Y | 1 |
Reed, PS | 1 |
Dixon, SR | 1 |
Boura, JA | 1 |
O'Neill, WW | 1 |
Kahn, JK | 1 |
Jo, SH | 1 |
Koo, BK | 1 |
Youn, TJ | 1 |
Kim, HS | 1 |
Heep, HW | 1 |
Müller-Lüdecke, H | 1 |
Reither, M | 1 |
Klingmüller, V | 1 |
Vlietstra, RE | 1 |
Nunn, CM | 1 |
Narvarte, J | 1 |
Browne, KF | 1 |
Ogle, GD | 1 |
Swinburn, MJ | 1 |
McCredie, RM | 1 |
Hoogewoud, HM | 1 |
Petropoulos, P | 1 |
Jevnikar, AM | 1 |
Finnie, KJ | 1 |
Dennis, B | 1 |
Plummer, DT | 1 |
Avila, A | 1 |
Linton, AL | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Benefit of Transradial Approach in Chronic Kidney Disease Population Undergoing Cardiac Catheterization, A Single Center Randomized Controlled Trial[NCT02933892] | Phase 4 | 100 participants (Anticipated) | Interventional | 2016-10-31 | Recruiting | ||
Efficacy of Oral Sodium Chloride vs iv Sodium Chloride in the Prevention of Contrast Nephropathy in Outpatients[NCT03476460] | Phase 2 | 269 participants (Actual) | Interventional | 2014-03-01 | Completed | ||
Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease (ENRICH): A Randomized Controlled Trial[NCT05283512] | 254 participants (Anticipated) | Interventional | 2022-04-20 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for ioxaglate and Kidney Diseases
Article | Year |
---|---|
The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
Topics: Aged; Aged, 80 and over; Consumer Product Safety; Contrast Media; Evidence-Based Medicine; Female; H | 2009 |
9 trials available for ioxaglate and Kidney Diseases
Article | Year |
---|---|
Ioxaglate Versus IoDixanol for the Prevention of Contrast-Induced Nephropathy: The IDPC Trial.
Topics: Aged; Contrast Media; Coronary Angiography; Creatinine; Humans; Ioxaglic Acid; Kidney Diseases; Risk | 2023 |
Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic rena
Topics: Aged; Angioplasty, Balloon; Contrast Media; Coronary Angiography; Coronary Artery Disease; Creatinin | 2009 |
Preventing acute decrease in renal function induced by coronary angiography (PRECORD): a prospective randomized trial.
Topics: Acute Disease; Biomarkers; Contrast Media; Coronary Angiography; Creatinine; Female; Fluid Therapy; | 2009 |
Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty.
Topics: Acetylcysteine; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Female; | 2012 |
N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial.
Topics: Acetylcysteine; Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Cardiac Catheterization; | 2005 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
[Use of hypo-osmolar contrast media in urography--results of an interindividual, randomized double-blind study].
Topics: Adult; Aged; Clinical Trials as Topic; Contrast Media; Double-Blind Method; Female; Humans; Iodobenz | 1984 |
[Initial trials using Hexabrix in excretory urography in childhood].
Topics: Child; Child, Preschool; Contrast Media; Diagnosis, Differential; Humans; Infant; Iodobenzoates; Iox | 1981 |
Nephrotoxicity of high- and low-osmolality contrast media.
Topics: Adult; Aged; Contrast Media; Coronary Angiography; Diatrizoate; Female; Humans; Iohexol; Ioxaglic Ac | 1988 |
10 other studies available for ioxaglate and Kidney Diseases
Article | Year |
---|---|
An experimental study on the preventive effects of N-acetyl cysteine and ozone treatment against contrast-induced nephropathy.
Topics: Acetylcysteine; Animals; Antioxidants; Contrast Media; Creatinine; Ioxaglic Acid; Kidney; Kidney Dis | 2018 |
Constriction of the vasa recta, the vessels supplying the area at risk for acute kidney injury, by four different iodinated contrast media, evaluating ionic, nonionic, monomeric and dimeric agents.
Topics: Analysis of Variance; Angiotensin II; Animals; Contrast Media; Diatrizoate; Humans; Iohexol; Ioxagli | 2010 |
Effect of sodium bicarbonate in an experimental model of radiocontrast nephropathy.
Topics: Animals; Contrast Media; Disease Models, Animal; Female; Infusions, Intravenous; Ioxaglic Acid; Kidn | 2010 |
Effects of gentamicin, lipopolysaccharide, and contrast media on immortalized proximal tubular cells.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Calcium; Contrast Media; Disease Models, Animal; Gentamic | 2002 |
Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.
Topics: Aged; Chronic Disease; Contrast Media; Coronary Disease; Female; Follow-Up Studies; Hemodynamics; Hu | 2005 |
Comparison of the usefulness of gadodiamide and iodine mixture versus iodinated contrast alone for prevention of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography.
Topics: Aged; Aged, 80 and over; Chronic Disease; Contrast Media; Coronary Angiography; Female; Gadolinium D | 2007 |
Conclusion of recent 'osmolality trials' in preventing contrast-induced nephropathy by NAC--what is the standard?
Topics: Angiography; Contrast Media; Cystatin C; Cystatins; Glomerular Filtration Rate; Humans; Iohexol; Iox | 2008 |
Contrast nephropathy after coronary angioplasty in chronic renal insufficiency.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Disease; Cr | 1996 |
Ioxaglate in paediatric angiocardiography.
Topics: Adolescent; Angiocardiography; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Inf | 1991 |
Renal embolization: a study of the interaction of contrast media and ethanol.
Topics: Aged; Drug Interactions; Embolization, Therapeutic; Ethanol; Humans; Iohexol; Iopamidol; Ioxaglic Ac | 1987 |